Integrated Investment Consultants’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,712
| Closed | -$184K | – | 279 |
|
|
2022
Q4 | $184K | Sell |
12,712
-19
| -0.1% | -$276 | 0.06% | 236 |
|
|
2022
Q3 | $243K | Hold |
12,731
| – | – | 0.1% | 180 |
|
|
2022
Q2 | $231K | Buy |
12,731
+39
| +0.3% | +$708 | 0.08% | 201 |
|
|
2022
Q1 | $320K | Buy |
12,692
+307
| +2% | +$7.74K | 0.09% | 211 |
|
|
2021
Q4 | $342K | Sell |
12,385
-14
| -0.1% | -$387 | 0.09% | 209 |
|
|
2021
Q3 | $400K | Buy |
12,399
+152
| +1% | +$4.9K | 0.12% | 162 |
|
|
2021
Q2 | $375K | Sell |
12,247
-3,129
| -20% | -$95.8K | 0.11% | 168 |
|
|
2021
Q1 | $468K | Buy |
15,376
+4,500
| +41% | +$137K | 0.16% | 119 |
|
|
2020
Q4 | $215K | Buy |
10,876
+13
| +0.1% | +$257 | 0.08% | 219 |
|
|
2020
Q3 | $142K | Buy |
+10,863
| New | +$142K | 0.07% | 194 |
|